未登录 分享 收藏
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring 尿路上皮癌化疗免疫治疗试验的差异化删失重分析 Meirson, Tomer; Ofer, Jonathan; Zimhony-Nissim, Noa; Bareket-Samish, Avital; Markel, Gal; Neiman, Victoria; Cherny, Nathan; Goldstein, Daniel A.; Gyawali, Bishal; Tannock, Ian; Rosenbaum, Eli 分享 收藏
KEYMAKER-U02 substudy 02C: Neoadjuvant pembrolizumab (pembro) and investigational agents followed by adjuvant pembro for stage IIIB-D melanoma KEYMAKER-U02 子研究 02C：新辅助培美曲塞（pembro）和研究性药物，随后进行辅助培美曲塞治疗用于IIIB-D期黑色素瘤 Long, G. V.; Robert, C.; Hill, A. G.; Marqueste, C. Gaudy; Portnoy, D.; Shapira, R.; Cohen, J. E.; Khattak, M. A.; Lebbe, C.; Menzies, A. M.; Markel, G.; Bar-Sela, G.; Sharfman, W. H.; Pages, C.; Hamid, O.; Mehnert, J. M.; Jing, N.; Kalabis, M.; Krepler, C.; Dummer, R. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology Meirson, Tomer; Nardone, Valerio; Pentimalli, Francesca; Markel, Gal; Bomze, David; D'Apolito, Maria; Correale, Pierpaolo; Giordano, Antonio; Pirtoli, Luigi; Porta, Camillo; Gray, Steven G.; Mutti, Luciano 分享 收藏
分享 收藏
Trends in Women's Leadership of Oncology Clinical Trials Waldhorn, Ithai; Dekel, Ayelet; Morozov, Anna; Alon, Elisa Sardas; Stave, Danielle; Ben Tsrooya, Noam; Schlosser, Shir; Markel, Gal; Bomze, David; Meirson, Tomer 分享 收藏
REMOVAL OF SOLUBLE TUMOR NECROSIS FACTORS RECEPTORS 1/2 IN PATIENTS WITH METASTATIC SOLID TUMORS USING IMMUNE APHERESIS Tamir, Ayala; Harati, Hagit; Asher, Nethanel; Stoff, Ronen; Grynberg, Shirly; Segal, Robert; Ostrowski, Adam; Florin, Lawrence; Shapira-Frommer, Ronnie; Markel, Gal 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response Besser, Michal J.; Itzhaki, Orit; Ben-Betzalel, Guy; Zippel, Douglas B.; Zikich, Dragoslav; Kubi, Adva; Brezinger, Karin; Nissani, Abraham; Levi, Michal; Zeltzer, Li-at; Ben-Nun, Alon; Asher, Nethanel; Shimoni, Avichai; Nagler, Arnon; Markel, Gal; Shapira-Frommer, Ronnie; Schachter, Jacob 分享 收藏
分享 收藏
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactions Baruch, Erez Nissim; Ortenberg, Rona; Avivi, Camila; Anafi, Liat; Dick-Necula, Daniela; Stossel, Chani; Moshkovits, Yonatan; Itzhaki, Orit; Besser, Michal Judith; Schachter, Jacob; Barshack, Iris; Markel, Gal 分享 收藏
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients ALL和NHL患者内部产生的CD19 car-t细胞的头对头比较 Itzhaki, Orit; Jacoby, Elad; Nissani, Abraham; Levi, Michal; Nagler, Arnon; Kubi, Adva; Brezinger, Karin; Brayer, Hadar; Zeltzer, Li-at; Rozenbaum, Meir; Vernitsky, Helly; Markel, Gal; Toren, Amos; Avigdor, Abraham; Schachter, Jacob; Besser, Michal J. 分享 收藏
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy 来自人类前列腺肿瘤的肿瘤浸润淋巴细胞显示出抗肿瘤反应性和过继细胞治疗的潜力 Yunger, Sharon; Barel, Assaf; Zeltzer, Li-at; Fridman, Eddie; Raviv, Gil; Laufer, Menachem; Schachter, Jacob; Markel, Gal; Itzhaki, Orit; Besser, Michal J. 分享 收藏
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study Bar, Jair; Markel, Gal; Gottfried, Teodor; Percik, Ruth; Leibowitz-Amit, Raya; Berger, Raanan; Golan, Talia; Daher, Sameh; Taliansky, Alisa; Dudnik, Elizabeth; Shulman, Katerina; Urban, Damien; Onn, Amir 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
